These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31808457)

  • 1. L-carnitine supplementation as a potential therapy for suspected hyperammonaemic encephalopathy.
    Khakwani A; Gannon D
    J R Coll Physicians Edinb; 2019 Dec; 49(4):301-303. PubMed ID: 31808457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium valproate-related hyperammonaemic encephalopathy.
    Pegg EJ; Zaman F
    BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24722719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe hyperammonaemic encephalopathy resulting from the overlap between hepatic and valproate encephalopathy.
    Izadi Firouzabadi L; Geer K; Mead P;
    Postgrad Med J; 2018 Nov; 94(1117):664. PubMed ID: 30397004
    [No Abstract]   [Full Text] [Related]  

  • 4. Valproate-Associated Hyperammonaemic Encephalopathy.
    Anthonipillai P; Sharp G; Kimber J; Ziauddin V
    Acute Med; 2022; 21(1):43-46. PubMed ID: 35342909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The decreased level of plasma carnitine in patients with epilepsy].
    Belousova ED
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):106-110. PubMed ID: 28745680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy].
    Yamada H; Shishido T; Mukai T; Araki M; Naka H; Tokinobu H
    Rinsho Shinkeigaku; 2019 May; 59(5):258-263. PubMed ID: 31061301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of hyperammonaemic encephalopathy due to valproic acid.
    Prins MC; van Meijel JJ
    Neth J Med; 2011 Sep; 69(9):389-91. PubMed ID: 21978982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Valproate-induced hyperammonemic encephalopathy].
    Granel B; Gavaret M; Le Baut X; Sautereau N; Rodriguez D; Rossi P; Bagnères D; Demoux AL; Francès Y
    Rev Med Interne; 2011 Jun; 32(6):e72-5. PubMed ID: 20633966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Valproate-induced hyperammonemic encephalopathy in a neonate: treatment with carglumic acid].
    Fernández Colomer B; Rekarte García S; García López JE; Pérez González C; Montes Granda M; Coto Cotallo GD
    An Pediatr (Barc); 2014 Oct; 81(4):251-5. PubMed ID: 24315420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid-induced hyperammonaemic coma and unrecognised portosystemic shunt.
    Nzwalo H; Carrapatoso L; Ferreira F; Basilio C
    Epileptic Disord; 2013 Jun; 15(2):207-10. PubMed ID: 23774155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting.
    Dealberto MJ
    Int Clin Psychopharmacol; 2007 Nov; 22(6):330-7. PubMed ID: 17917551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate overdose leading to hyperammonaemic encephalopathy.
    Sharma DS; Gupta S; Sharma P
    BMJ Case Rep; 2023 Jul; 16(7):. PubMed ID: 37423637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate induced non hepatic hyperammonaemic encephalopathy (VNHE)--a study from tertiary care referral university hospital, north India.
    Mehndiratta MM; Mehndiratta P; Phul P; Garg S
    J Pak Med Assoc; 2008 Nov; 58(11):627-31. PubMed ID: 19024136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carnitine in the treatment of valproic acid-induced toxicity.
    Lheureux PE; Hantson P
    Clin Toxicol (Phila); 2009 Feb; 47(2):101-11. PubMed ID: 19280426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate Induced Hyperammonemic Encephalopathy.
    Qayyum W; Yousafzai ZA; Iqbal MS; Khan S; Amin QK; Shafiqs I
    J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S1038-S1039. PubMed ID: 36550671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-hyperammonaemia valproate-induced encephalopathy: A case report.
    Chen L; Xu Z; Huang H
    J Clin Pharm Ther; 2022 Mar; 47(3):415-419. PubMed ID: 34462930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of carnitine supplementation in valproate-induced hyperammonaemia.
    Böhles H; Sewell AC; Wenzel D
    Acta Paediatr; 1996 Apr; 85(4):446-9. PubMed ID: 8740302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifactorial non-cirrhotic hyperammonaemic encephalopathy.
    Triplett KE; Murray R; Anstey M
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29523611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lesson of the month 1: Sodium valproate-induced encephalopathy.
    Camilleri L
    Clin Med (Lond); 2018 Oct; 18(5):430-432. PubMed ID: 30287443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy.
    Mock CM; Schwetschenau KH
    Am J Health Syst Pharm; 2012 Jan; 69(1):35-9. PubMed ID: 22180549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.